Search Within

Department of Medicine

Formats
  1. Journal Article (19620)
  2. Meeting Abstract (16084)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (237)
  10. Miscellaneous (91)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22367)
  2. Hematologic Malignancies, Division of (13308)
  3. Center for Hematologic Malignancies (11082)
  4. GSK Faculty (10658)
  5. Survivorship Research (9352)
  6. Division of Subspecialty Medicine (7560)

More Groups

People
  1. Robert Motzer (1251)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1158)
  2. 2024 (2293)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1411)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (904)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2898)
  5. Oxford University Press (2304)
  6. Nature Publishing Group (2122)

More Publishers

Results (39711)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of androgen receptor dynamics through immunofluorescent staining of circulating tumor cells in castration-resistant prostate cancer
    Meeting Abstract

    Barnett, E.; Gupta, S.; Erazo, T.; Lam, E.; Carbone, E.; Zanone, M.; Nystrom, L.; Gajar, R. N.; Wenstrup, R.; Scher, H. I.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Real world treatment patterns and survival by germline BRCA (gBRCA) mutation status in patients with HER2-negative early breast cancer (eBC) in the US community oncology setting: A retrospective observational study
    Meeting Abstract

    Andersen, J. C.; Earla, J. R.; Fulcher, N.; Ndukum, J.; Robert, N. J.; Robson, M. E.; Li, W.; Mejia, J.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Integrating technology to support data management abstraction of adverse events (AE) and concomitant medications (ConMed) from the electronic health record (EHR) to sponsor electronic data capture (EDC) systems using design thinking (DT) methodology
    Meeting Abstract

    Yuravlivker, L.; Buckley, M. T.; Bouvier, N.; Jeevarathnam, S.; Lazan, S.; Panchal, R.; McKellop, M.; Lengfellner, J. M.; Terzulli, S. L.; Sabbatini, P.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Pooled analysis of cytokine release syndrome across cohorts in patients with advanced synovial sarcoma
    Meeting Abstract

    D'Angelo, S. P.; Ganjoo, K. N.; Blay, J. Y.; Valverde, C.; Araujo, D. M.; Abdul Razak, A. R.; Le Cesne, A.; Schuetze, S.; Wagner, M. J.; Attia, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 2 study of alrizomadlin, a novel MDM2/p53 inhibitor, in combination with pembrolizumab for treatment of patients with malignant peripheral nerve sheath tumor (MPNST)
    Meeting Abstract

    Somaiah, N.; Van Tine, B. A.; Chmielowski, B.; Drabick, J. J.; Chawla, S. P.; McKean, M.; Spira, A. I.; O'Byrne, K. J.; Foresto, S. A.; Movva, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Prevalence and patterns of breast white adipose tissue inflammation among American Black women and indigenous Nigerian women with early-stage breast cancer
    Meeting Abstract

    Liu, B.; Shen, S.; Omoyiola, O. Z.; Odujoko, O. O.; Sharma, A.; Ogunleye, G. S.; Owoade, I. A.; Olasehinde, O.; Wuraola, F. O.; Ntiamoah, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Experiences with pain management for survivors of complex cancers: Focus on opioids and cannabis
    Meeting Abstract

    Salz, T.; Chimonas, S.; Jinna, S.; Brens, J.; Kriplani, A.; Salner, A. L.; Rabinowits, G.; Currier, M.; Daly, R. M.; Korenstein, D.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Associations between psychosocial risk factors and immune checkpoint inhibitor outcomes
    Meeting Abstract

    Derry-Vick, H.; Zaemes, J. P.; Ahn, J.; Pascual, L.; Sinclaire, B.; Lev-Ari, S.; Alaoui, A.; Sridhar, A.; Adams, D.; Della Pia, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Long-term follow up of selinexor maintenance in patients with TP53 wt advanced or recurrent endometrial cancer: A pre-specified subgroup analysis from the phase 3 ENGOT-EN5/GOG-3055/SIENDO study
    Meeting Abstract

    Slomovitz, B. M.; Perez-Fidalgo, J. A.; Hamilton, E. P.; Valabrega, G.; Van Gorp, T.; Sehouli, J.; Klat, J.; Levy, T.; Welch, S.; Richardson, D. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The impact of population pharmacogenomics and risk allele frequencies on cisplatin-induced peripheral sensory neuropathy (PSN)
    Meeting Abstract

    Nakshatri, S.; Dinh, P. C.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Fung, C.; Kollmannsberger, C. K.; Huddart, R. A.; Martin, N. E.; Einhorn, L. H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save